Insider Transactions in Q2 2022 at Meridian Bioscience Inc (VIVO)
Insider Transaction List (Q2 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 27
2022
|
John P. Kenny Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
61,437
-18.81%
|
$1,843,110
$30.39 P/Share
|
|
Jun 27
2022
|
John P. Kenny Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
61,437
+15.83%
|
$614,370
$10.1 P/Share
|
|
Jun 24
2022
|
John P. Kenny Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
13,559
-4.87%
|
$406,770
$30.0 P/Share
|
|
Jun 24
2022
|
John P. Kenny Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
13,559
+4.64%
|
$135,590
$10.1 P/Share
|
|
Jun 23
2022
|
John P. Kenny Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
19,956
-7.0%
|
$578,724
$29.98 P/Share
|
|
Jun 23
2022
|
John P. Kenny Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
19,956
+3.41%
|
$239,472
$12.3 P/Share
|
|
Jun 22
2022
|
John P. Kenny Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
44,651
-14.41%
|
$1,294,879
$29.72 P/Share
|
|
Jun 22
2022
|
John P. Kenny Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
44,651
+12.6%
|
$625,114
$14.5 P/Share
|